[ad_1]
according to The Washington Post, the change was made in response to the outcry sparked by online marketing by stem cell clinics touting unapproved treatments for everything from joint pain to Alzheimer's disease. At best, many clinics are a waste of money. At worst, they can be extremely dangerous.
The policy includes a list of unauthorized substances that can not be advertised, including those containing ephedra, human chorionic gonadotropin (hCG) used to control weight, and herbal and dietary supplements containing active ingredients or pharmaceutical ingredients. It also explains how health-related advertising varies from country to country.
Google recognizes that "good actors" are conducting important research that could lead to significant breakthroughs, and the company said that it would still allow advertising for clinical trial research. "Digital advertising is driving an open Internet for people around the world, allowing billions of people to ask questions, find answers, and discover new ideas," said Adrienne Biddings, Google Policy Advisor. . "We know that the ecosystem of digital ads can only flourish if it is a safe and trusted place for users."
[ad_2]
Source link